---
title: "Gongdong Medical plans to spend 45.65 million yuan to acquire a 55% stake in Jindongsheng to expand sales channels in the northwest region"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/224543229.md"
description: "Gongdong Medical announced plans to acquire 55% of Urumqi Jindongsheng Trading Co., Ltd. for 45.65 million yuan to expand its sales channels in the northwest region. This transaction will make Gongdong Medical the sole owner of Jindongsheng, further enhancing its market share"
datetime: "2025-01-10T08:17:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/224543229.md)
  - [en](https://longbridge.com/en/news/224543229.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/224543229.md)
generator: "portal-rs"
---

# Gongdong Medical plans to spend 45.65 million yuan to acquire a 55% stake in Jindongsheng to expand sales channels in the northwest region

According to the Zhitong Finance APP, Gongdong Medical (605369.SH) announced that based on the company's business strategy and development plan, in order to further expand sales channels in the northwest region and increase market share, the company signed the "Equity Transfer Agreement between Zhejiang Gongdong Medical Devices Co., Ltd. and Liu Dongming regarding Urumqi Jindongsheng Trading Co., Ltd." with Liu Dongming and Urumqi Jindongsheng Trading Co., Ltd. (referred to as "Jindongsheng") on January 10, 2025. The company intends to use its own funds of 45.65 million yuan to acquire 55% of the equity held by Liu Dongming in Jindongsheng, corresponding to a registered capital of 5.5 million yuan. After the completion of this investment, the company will hold 100% of the shares of Jindongsheng, and Jindongsheng will become a wholly-owned subsidiary of the company

### Related Stocks

- [605369.CN](https://longbridge.com/en/quote/605369.CN.md)
- [603326.CN](https://longbridge.com/en/quote/603326.CN.md)
- [01137.HK](https://longbridge.com/en/quote/01137.HK.md)
- [00694.HK](https://longbridge.com/en/quote/00694.HK.md)

## Related News & Research

- [SynAct Pharma bolsters resomelagon data as it readies Phase 3 and weighs strategic deals](https://longbridge.com/en/news/298195637.md)
- [M Stanley: MOF Capital Injection Into State-owned Insurers Seen Neutral; Focus on Execution Details](https://longbridge.com/en/news/298164007.md)
- [Cyclezyme to buy Ragn-Sells melanin patent, pays via shares for 7.9% stake](https://longbridge.com/en/news/298137821.md)
- [Revolut takes step closer to US bank launch after clearing key regulatory hurdle](https://longbridge.com/en/news/297933534.md)
- [22:00 ETCarestream Healthcare International améliore le détecteur DRX-LC pour améliorer les performances d'imagerie de grande longueur](https://longbridge.com/en/news/297978656.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**